Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Jan-17 4:27 PM View:  | Sussman S Donald | Arno Therapeutics, Inc (ARNI) | 30-Dec-16 | Sale | 4,285,110 | -- | -- | (86%) 5.0M to 714.28K | |
| 05-Oct-16 5:36 PM View: | Tanen David M Secretary Director | Arno Therapeutics, Inc (ARNI) | 03-Oct-16 | Purchase | 142,857 | -- | -- | 26% 552.42K to 695.27K | |
| 17-Aug-16 6:03 PM View: | Belldegrun Arie Director | Arno Therapeutics, Inc (ARNI) | 15-Aug-16 | Purchase Duplicate | 714,285 | -- | -- | 22% 3.22M to 3.93M | |
| 08-Sep-16 4:02 PM View: | Sussman S Donald 10% Owner | Arno Therapeutics, Inc (ARNI) | 15-Aug-16 | Purchase | 714,285 | -- | -- | 16% 4.47M to 5.19M | |
| 17-Aug-16 6:02 PM View: | Kariv Tomer Director | Arno Therapeutics, Inc (ARNI) | 15-Aug-16 | Purchase Duplicate | 714,285 | -- | -- | 26% 2.76M to 3.47M | |
| 14-Jan-16 5:20 PM View: | Tanen David M Secretary Director | Arno Therapeutics, Inc (ARNI) | 12-Jan-16 | Purchase | 362,015 | $0.35 | $126,705.00 | 190% 190.4K to 552.42K | |
| 11-Apr-16 4:22 PM View: | Kariv Tomer Director | Arno Therapeutics, Inc (ARNI) | 12-Jan-16 | Purchase | 1,448,060 | $0.35 | $506,822.00 | 111% 1.31M to 2.76M | |
| 14-Jan-16 5:19 PM View: | Kariv Tomer Director | Arno Therapeutics, Inc (ARNI) | 12-Jan-16 | Purchase Duplicate | 1,448,060 | $0.35 | $506,822.00 | 111% 1.31M to 2.76M | |
| 14-Jan-16 5:20 PM View: | Zukiwski Alexander A VP & Chief Medical Officer Director | Arno Therapeutics, Inc (ARNI) | 12-Jan-16 | Purchase | 144,806 | $0.35 | $50,682.10 | 124% 117.03K to 261.83K | |
| 14-Jan-16 5:19 PM View: | Belldegrun Arie Director | Arno Therapeutics, Inc (ARNI) | 12-Jan-16 | Purchase | 2,162,350 | $0.35 | $756,821.00 | 205% 1.06M to 3.22M | |
| 14-Jan-16 5:20 PM View: | Ruchefsky Steven B Director | Arno Therapeutics, Inc (ARNI) | 12-Jan-16 | Purchase | 2,876,630 | $0.35 | $1,006,820.00 | 180% 1.6M to 4.47M | |
| 31-Oct-13 7:38 PM View: | Ruchefsky Steven B Director | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Grant | 41,666 | $2.40 | $99,998.40 | 13% 311.67K to 353.33K | |
| 05-Nov-13 10:08 AM View: | Belldegrun Arie Director | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Grant | 21,666 | $2.40 | $51,998.40 | 29% 74.78K to 96.44K | |
| 31-Oct-13 7:36 PM View: | Mattes Glenn R. President & CEO Director | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Conversion | 22,218 | $2.40 | $53,323.20 | 65% 34.15K to 56.37K | |
| 31-Oct-13 7:53 PM View: | Zukiwski Alexander A VP & Chief Medical Officer | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Conversion | 66,652 | $2.40 | $159,965.00 | 765% 8.71K to 75.36K | |
| 31-Oct-13 7:33 PM View: | Kariv Tomer Director | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Purchase | 416,666 | -- | -- | 47% 891.45K to 1.31M | |
| 31-Oct-13 7:47 PM View: | Hamilton William F Phd Director | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Purchase | 20,833 | -- | -- | 1672% 1.25K to 22.08K | |
| 05-Nov-13 10:08 AM View: | Belldegrun Arie Director | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Purchase | 83,332 | -- | -- | 43% 191.79K to 275.13K | |
| 31-Oct-13 7:33 PM View: | Kariv Tomer Director | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Grant | 33,332 | $2.40 | $79,996.80 | 8% 413.77K to 447.1K | |
| 31-Oct-13 7:40 PM View: | Proniuk Stefan VP of Product Development | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Grant | 666 | $2.40 | $1,598.40 | 135% 0.49K to 1.16K | |
| 05-Nov-13 10:08 AM View: | Belldegrun Arie Director | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Grant | 11,666 | $2.40 | $27,998.40 | 47% 24.6K to 36.27K | |
| 31-Oct-13 7:38 PM View: | Ruchefsky Steven B Director | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Conversion | 555,440 | $2.40 | $1,333,060.00 | 157% 353.33K to 908.77K | |
| 05-Nov-13 10:08 AM View: | Belldegrun Arie Director | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Conversion | 288,828 | $2.40 | $693,187.00 | 299% 96.44K to 385.27K | |
| 31-Oct-13 7:36 PM View: | Mattes Glenn R. President & CEO Director | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Purchase | 20,833 | -- | -- | 37% 56.37K to 77.2K | |
| 31-Oct-13 7:53 PM View: | Zukiwski Alexander A VP & Chief Medical Officer | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Purchase | 41,666 | -- | -- | 55% 75.36K to 117.03K | |
| 31-Oct-13 7:36 PM View: | Mattes Glenn R. President & CEO Director | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Grant | 1,666 | $2.40 | $3,998.40 | 5% 32.49K to 34.15K | |
| 31-Oct-13 7:53 PM View: | Zukiwski Alexander A VP & Chief Medical Officer | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Grant | 5,000 | $2.40 | $12,000.00 | 135% 3.71K to 8.71K | |
| 31-Oct-13 7:33 PM View: | Kariv Tomer Director | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Conversion | 444,352 | $2.40 | $1,066,440.00 | 99% 447.1K to 891.46K | |
| 31-Oct-13 7:40 PM View: | Proniuk Stefan VP of Product Development | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Conversion | 8,887 | $2.40 | $21,328.80 | 766% 1.16K to 10.05K | |
| 05-Nov-13 10:08 AM View: | Belldegrun Arie Director | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Conversion | 155,523 | $2.40 | $373,255.00 | 429% 36.27K to 191.79K | |
| 31-Oct-13 7:38 PM View: | Ruchefsky Steven B Director | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Purchase | 687,500 | -- | -- | 76% 908.77K to 1.6M | |
| 05-Nov-13 10:08 AM View: | Belldegrun Arie Director | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Purchase | 395,832 | -- | -- | 103% 385.27K to 781.11K | |
| 09-Oct-13 5:31 PM View: | Wexford Capital LLC | Arno Therapeutics, Inc (ARNI) | 04-Oct-13 | Market Sale | 325 | $0.48 | $156.00 | (< 1%) 3.25M to 3.25M | 100% |
| 03-Jun-13 4:46 PM View: | Belldegrun Arie Director | Arno Therapeutics, Inc (ARNI) | 28-May-13 | Acquisition (other) | 64,445 | $0.30 | $19,333.50 | 9% 730.65K to 795.09K | |
| 30-May-13 5:04 PM View: | Proniuk Stefan VP of Product Development | Arno Therapeutics, Inc (ARNI) | 28-May-13 | Acquisition (other) | 1,289 | $0.30 | $386.70 | 48% 2.67K to 3.96K | |
| 04-Jun-13 4:16 PM View: | Ruchefsky Steven B Director | Arno Therapeutics, Inc (ARNI) | 28-May-13 | Acquisition (other) | 80,556 | $0.30 | $24,166.80 | 3% 2.41M to 2.49M | |
| 30-May-13 5:05 PM View: | Zukiwski Alexander A VP & Chief Medical Officer | Arno Therapeutics, Inc (ARNI) | 28-May-13 | Acquisition (other) | 9,667 | $0.30 | $2,900.10 | 48% 20.0K to 29.67K | |
| 05-Jun-13 4:05 PM View: | Kariv Tomer Director | Arno Therapeutics, Inc (ARNI) | 28-May-13 | Acquisition (other) | 66,666 | $0.30 | $19,999.80 | 2% 3.24M to 3.31M | |
| 30-May-13 5:02 PM View: | Mattes Glenn R. President & CEO Director | Arno Therapeutics, Inc (ARNI) | 28-May-13 | Acquisition (other) | 3,222 | $0.30 | $966.60 | 1% 256.67K to 259.89K | |
| 23-May-13 4:57 PM View: | Thurman Randy H Director | Arno Therapeutics, Inc (ARNI) | 22-May-13 | Market Purchase | 2,500 | $0.50 | $1,250.00 | 33% 7.5K to 10.0K | (100%) |
| 23-May-13 4:57 PM View: | Thurman Randy H Director | Arno Therapeutics, Inc (ARNI) | 21-May-13 | Market Purchase | 7,500 | $0.50 | $3,750.00 | 100% 0 to 7.5K | (100%) |
| 06-May-13 5:10 PM View: | Proniuk Stefan VP of Product Development | Arno Therapeutics, Inc (ARNI) | 29-Apr-13 | Acquisition (other) | 1,333 | $0.30 | $399.90 | 100% 1.33K to 2.67K | |
| 07-May-13 10:12 AM View: | Mattes Glenn R. President & CEO Director | Arno Therapeutics, Inc (ARNI) | 29-Apr-13 | Acquisition (other) | 3,333 | $0.30 | $999.90 | 1% 253.33K to 256.67K | |
| 07-May-13 9:14 AM View: | Kariv Tomer Director | Arno Therapeutics, Inc (ARNI) | 29-Apr-13 | Acquisition (other) | 113,972 | $0.30 | $34,191.60 | 4% 3.13M to 3.24M | |
| 07-May-13 12:20 PM View: | Belldegrun Arie Director | Arno Therapeutics, Inc (ARNI) | 29-Apr-13 | Acquisition (other) | 66,666 | $0.30 | $19,999.80 | 10% 663.98K to 730.65K | |
| 07-May-13 9:15 AM View: | Zukiwski Alexander A VP & Chief Medical Officer | Arno Therapeutics, Inc (ARNI) | 29-Apr-13 | Acquisition (other) | 10,000 | $0.30 | $3,000.00 | 100% 10.0K to 20.0K | |
| 07-May-13 1:05 PM View: | Ruchefsky Steven B Director | Arno Therapeutics, Inc (ARNI) | 29-Apr-13 | Acquisition (other) | 83,333 | $0.30 | $24,999.90 | 4% 2.33M to 2.41M | |
| 09-Apr-13 5:40 PM View: | Mattes Glenn R. President & CEO Director | Arno Therapeutics, Inc (ARNI) | 27-Mar-13 | Acquisition (other) | 3,333 | $0.30 | $999.90 | 1% 250.0K to 253.33K | |
| 10-Apr-13 10:30 AM View: | Proniuk Stefan VP of Product Development | Arno Therapeutics, Inc (ARNI) | 27-Mar-13 | Acquisition (other) | 1,333 | $0.30 | $399.90 | 100% 0 to 1.33K | |
| 09-Apr-13 5:46 PM View: | Ruchefsky Steven B Director | Arno Therapeutics, Inc (ARNI) | 27-Mar-13 | Acquisition (other) | 83,333 | $0.30 | $24,999.90 | 4% 2.25M to 2.33M |
